Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAIROS: Rituximab intensification and maintenance in B-CLL
NCT02013817Phase 2Completed
- Sponsor
- Roche
- Start
- Oct 2005
- Primary completion
- Sep 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in chronic lymphocytic leukemia (CLL), sponsored by Roche. Started Oct 2005; status: completed.
02
Drugs
rituximab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT02013817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02013817.